NCT00812669 2025-07-08CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7Cancer Trials IrelandPhase 2 Completed52 enrolled
NCT00004192 2023-12-27Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's LymphomaUniversity of NebraskaPhase 2 Completed60 enrolled
NCT00278161 2018-11-05Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin's LymphomaSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2 Completed94 enrolled 8 charts
NCT01682044 2017-10-09Pegfilgrastim and Rituximab in Treating Patients With Untreated, Relapsed, or Refractory Follicular Lymphoma, Small Lymphocytic Lymphoma, or Marginal Zone LymphomaRoswell Park Cancer InstitutePhase 2 Completed20 enrolled 11 charts
NCT00816595 2017-06-15Pentostatin, Cyclophosphamide, and Rituximab With or Without Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaMayo ClinicPhase 2 Completed68 enrolled 7 charts